Lactoferrin for cell culture usually arrives from milk. Bovine milk lactoferrin is the common source, widely available at lower cost, but it differs from human lactoferrin in approximately 31% of its amino acid sequence, in glycosylation architecture, and in receptor binding, and commercial preparations vary in iron saturation and lot-to-lot consistency. It also carries adventitious agent risk, TSE/BSE risk, herd and seasonal variability, and a regulatory documentation burden. Human milk lactoferrin avoids the species mismatch but is rare, expensive, and difficult to source consistently.
Lacromin® is InVitria’s recombinant human holo-lactoferrin, produced on the ExpressTec™ rice grain-based expression platform (Oryza sativa) at the ISO 9001:2015-certified, cGMP-compliant facility in Junction City, Kansas. Purity is ≥ 90% rhLF and endotoxin is < 10 EU/mg on reconstituted solution, with no carrier protein, stabilizer, or preservative. It ships as the pink to reddish lyophilized powder characteristic of iron saturation, in 10 g and 100 g. In InVitria’s 2026 functional characterization, three lots carried baseline iron saturation of 77.5, 78.1, and 91.6%, released iron under acidic conditions and re-saturated to 90.2 to 93.8%, a reversible binding profile comparable to human milk lactoferrin.